Correlation Between Knight Therapeutics and JPMorgan Chase

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Knight Therapeutics and JPMorgan Chase at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Knight Therapeutics and JPMorgan Chase into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Knight Therapeutics and JPMorgan Chase Co, you can compare the effects of market volatilities on Knight Therapeutics and JPMorgan Chase and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Knight Therapeutics with a short position of JPMorgan Chase. Check out your portfolio center. Please also check ongoing floating volatility patterns of Knight Therapeutics and JPMorgan Chase.

Diversification Opportunities for Knight Therapeutics and JPMorgan Chase

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Knight and JPMorgan is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Knight Therapeutics and JPMorgan Chase Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on JPMorgan Chase and Knight Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Knight Therapeutics are associated (or correlated) with JPMorgan Chase. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of JPMorgan Chase has no effect on the direction of Knight Therapeutics i.e., Knight Therapeutics and JPMorgan Chase go up and down completely randomly.

Pair Corralation between Knight Therapeutics and JPMorgan Chase

Assuming the 90 days trading horizon Knight Therapeutics is expected to generate 4.72 times less return on investment than JPMorgan Chase. In addition to that, Knight Therapeutics is 1.18 times more volatile than JPMorgan Chase Co. It trades about 0.03 of its total potential returns per unit of risk. JPMorgan Chase Co is currently generating about 0.15 per unit of volatility. If you would invest  1,899  in JPMorgan Chase Co on September 1, 2024 and sell it today you would earn a total of  1,445  from holding JPMorgan Chase Co or generate 76.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Knight Therapeutics  vs.  JPMorgan Chase Co

 Performance 
       Timeline  
Knight Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Knight Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Knight Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
JPMorgan Chase 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, JPMorgan Chase displayed solid returns over the last few months and may actually be approaching a breakup point.

Knight Therapeutics and JPMorgan Chase Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Knight Therapeutics and JPMorgan Chase

The main advantage of trading using opposite Knight Therapeutics and JPMorgan Chase positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Knight Therapeutics position performs unexpectedly, JPMorgan Chase can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in JPMorgan Chase will offset losses from the drop in JPMorgan Chase's long position.
The idea behind Knight Therapeutics and JPMorgan Chase Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Directory
Find actively traded commodities issued by global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA